Skip to content

Akershus Cardiac Examination (ACE) 1950 Study

Akershus Cardiac Examination 1950 Study - a Cohort Study on Cardio- and Cerebrovascular Disease in 62-65-year-old Subjects

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01555411
Acronym
ACE1950
Enrollment
3706
Registered
2012-03-15
Start date
2012-09-30
Completion date
2050-12-31
Last updated
2024-05-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation, Cardiovascular Diseases, Cerebrovascular Disorders, Heart Failure, Mild Cognitive Impairment

Keywords

Cardiovascular epidemiology, Prospective, observational cohort study, Biomarkers, Cardio- and cerebrovascular imaging

Brief summary

Akershus Cardiac Examination (ACE) 1950 Study is a large, observational, prospective, longitudinal, population-based cohort study. The overall aim is to establish an extensive cardio- and cerebrovascular age cohort of elderly subjects for various longitudinal long-term follow-up studies of cardiovascular and cerebrovascular disease.

Detailed description

Design: The Akershus Cardiac Examination (ACE) 1950 Study is a population-based, prospective, cerebro- and cardiovascular age-cohort study of all men and women born in 1950 in Akershus County, Norway. Time schedule: Study inclusion and baseline examinations took place in the period September 2012 - May 2015. Current status: 10-year follow-up examinations of all participants are undertaken in 2023-2025, and sub-studies are ongoing.

Interventions

None listed

Sponsors

University Hospital, Akershus
CollaboratorOTHER
Vestre Viken Hospital Trust
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
62 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Resident in Akershus County (as per October 2011, prior to study invitation) * Born in the year of 1950 * Ability to consent to participation

Design outcomes

Primary

MeasureTime frame
Outcomes related to CVD and CV-associated conditionsMaximum 35 years

Secondary

MeasureTime frame
Specific CV endpoints; e.g. acute myocardial infarction, heart failure, atrial fibrillation, etc.Maximum 35 years
Specific CV-associated conditions, including renal, cerebrovascular, pulmonary, etc.Maximum 35 years
Specific clinical phenotypes; e.g. myocardial and arterial structure and function, lung function, etc.Maximum 35 years

Other

MeasureTime frame
Impact of left atrial size and function measurements by echocardiography on stroke risk in an 62-65-year-old cohortWithin 35 years
Relation between cognitive function and sub-clinical CVD in a 62-65-year-old Norwegian population cohortMaximum 35 years

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 8, 2026